To investigate the mechanism by which DUXAP8 affects the malignant phenotype and chemotherapy resistance of HCC, RNA sequencing analysis of DUXAP8-knockdown HCC cells was performed. This evidence concerns the gene DUXAP8 and hepatocellular carcinoma.